CELZ CREATIVE MED TECHNOLOGY HLDG revenue, earnings and financials
For the quarter ended June 30, 2026, CREATIVE MED TECHNOLOGY HLDG reported revenue of $0, net income of −$1.51M and diluted EPS of −$0.41; over the last four quarters revenue was $3.00K and net income −$6.04M; for the fiscal year ended December 2025 revenue was $6.00K, down 45.5% on the year before.
CELZ annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $6.00K, gross profit $3.81K, operating income −$6.14M, net income −$6.00M (margin -99916.8%), EPS −$2.52
- Fiscal year ended Dec 2024: revenue $11.0K, gross profit $6.60K, operating income −$5.74M, net income −$5.49M (margin -49940.7%), EPS −$3.71
- Fiscal year ended Dec 2023: revenue $9.00K, gross profit $5.40K, operating income −$5.62M, net income −$5.29M (margin -58739.7%), EPS −$3.76
- Fiscal year ended Dec 2022: revenue $88.6K, gross profit $60.1K, operating income −$10.2M, net income −$10.1M (margin -11449.3%), EPS −$0.93
- Fiscal year ended Dec 2021: revenue $87.8K, gross profit $39.8K, operating income −$3.13M, net income $19.2M (margin 21892.8%), EPS $5.61
CELZ quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$1.51M, EPS −$0.41
- Quarter ended Mar 31, 2026: revenue $0 (down 100.0% year over year), net income −$1.41M, EPS −$0.38
- Quarter ended Dec 31, 2025 (from the annual report): revenue $3.00K (up 0.0% year over year), net income −$1.89M, EPS −$0.73
- Quarter ended Sep 30, 2025: revenue $0, net income −$1.24M, EPS −$0.48
- Quarter ended Jun 30, 2025: revenue $0 (down 100.0% year over year), net income −$1.23M, EPS −$0.48
- Quarter ended Mar 31, 2025: revenue $3.00K, net income −$1.64M, EPS −$0.83
- Quarter ended Dec 31, 2024 (from the annual report): revenue $3.00K (up 0.0% year over year), net income −$1.85M, EPS −$2.58
- Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$1.04M, EPS −$0.75
- Quarter ended Jun 30, 2024: revenue $8.00K, net income −$1.56M, EPS −$1.11
- Quarter ended Mar 31, 2024: revenue $0, net income −$1.04M, EPS $0.73
- Quarter ended Dec 31, 2023 (from the annual report): revenue $3.00K (down 83.9% year over year), net income −$1.68M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $6.00K (down 89.1% year over year), net income −$1.45M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $0, net income −$1.10M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $0 (down 100.0% year over year), net income −$1.05M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $18.6K (down 72.5% year over year), net income −$6.22M, EPS −$0.48
- Quarter ended Sep 30, 2022: revenue $55.0K (up 450.0% year over year), net income −$982K, EPS −$0.07
- Quarter ended Jun 30, 2022: revenue $0 (down 100.0% year over year), net income −$1.79M, EPS −$0.20
- Quarter ended Mar 31, 2022: revenue $15.0K, net income −$1.15M, EPS −$0.18
- Quarter ended Dec 31, 2021 (from the annual report): revenue $67.8K, net income −$3.88M, EPS −$3.57
- Quarter ended Sep 30, 2021: revenue $10.0K, net income −$1.84M, EPS −$0.75
CELZ cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$5.86M, share buybacks $10.0K
- Fiscal year ended Dec 2024: operating cash flow −$5.30M, share buybacks $175K
- Fiscal year ended Dec 2023: operating cash flow −$8.03M, share buybacks $271K
- Fiscal year ended Dec 2022: operating cash flow −$7.80M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow −$2.22M, share buybacks n/a
CELZ balance sheet
- Jun 30, 2026: cash n/a, total assets $9.38M, total liabilities $699K, shareholders' equity $8.65M
- Mar 31, 2026: cash n/a, total assets $6.44M, total liabilities $308K, shareholders' equity $6.11M
- Dec 31, 2025: cash n/a, total assets $7.81M, total liabilities $285K, shareholders' equity $7.51M
- Sep 30, 2025: cash n/a, total assets $5.85M, total liabilities $261K, shareholders' equity $5.59M
- Jun 30, 2025: cash n/a, total assets $7.11M, total liabilities $278K, shareholders' equity $6.83M
- Mar 31, 2025: cash n/a, total assets $8.35M, total liabilities $286K, shareholders' equity $8.06M
- Dec 31, 2024: cash n/a, total assets $6.67M, total liabilities $328K, shareholders' equity $6.34M
- Sep 30, 2024: cash n/a, total assets $6.89M, total liabilities $331K, shareholders' equity $6.56M
What is CELZ's revenue?
CREATIVE MED TECHNOLOGY HLDG reported $3.00K of revenue over its last four quarters, through June 30, 2026.
Is CELZ profitable?
No. CREATIVE MED TECHNOLOGY HLDG lost $6.04M over the last four quarters.
What is CELZ's EPS?
Diluted earnings per share over the last four quarters were −$2.00; −$0.41 in the latest quarter.